TESARO (TSRO) to Release Earnings on Monday

TESARO (NASDAQ:TSRO) will be issuing its quarterly earnings data after the market closes on Monday, February 26th. Analysts expect the company to announce earnings of ($2.35) per share for the quarter.

TESARO (NASDAQ TSRO) opened at $60.74 on Friday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.35 and a current ratio of 4.73. TESARO has a 1-year low of $55.02 and a 1-year high of $190.40. The firm has a market cap of $3,311.31, a price-to-earnings ratio of -7.20 and a beta of 1.25.

TSRO has been the topic of several research reports. Morgan Stanley lowered their price objective on shares of TESARO from $165.00 to $156.00 and set an “overweight” rating on the stock in a report on Tuesday, January 16th. Jefferies Group restated a “hold” rating and set a $124.00 price objective on shares of TESARO in a report on Friday, November 3rd. Credit Suisse Group restated an “outperform” rating and set a $150.00 price objective (down previously from $190.00) on shares of TESARO in a report on Thursday, January 18th. Leerink Swann upgraded shares of TESARO from a “market perform” rating to an “outperform” rating in a report on Wednesday, November 15th. Finally, BidaskClub upgraded shares of TESARO from a “strong sell” rating to a “sell” rating in a report on Tuesday, January 23rd. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $148.60.

In related news, SVP Martin H. Jr. Huber sold 829 shares of the stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $85.24, for a total transaction of $70,663.96. Following the completion of the transaction, the senior vice president now owns 8,101 shares in the company, valued at $690,529.24. The transaction was disclosed in a document filed with the SEC, which is available through this link. 40.50% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “TESARO (TSRO) to Release Earnings on Monday” was first published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://transcriptdaily.com/2018/02/25/tesaro-tsro-to-release-earnings-on-monday.html.


TESARO, Inc is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

Earnings History for TESARO (NASDAQ:TSRO)

Receive News & Ratings for TESARO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TESARO and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply